Journal of Gastrointestinal Surgery

Impact of Gastrointestinal Surgical Site Wound Complications on Long-term Healthcare Utilization.  25:503-511. 2021

SSAT PG/CME Committee Symposium Highlights: Perioperative Management—Best Practice in Surgical Quality and Safety.  25:339-350. 2021

Impact of Robotic Versus Laparoscopic Pyloroplasty on Short- and Long-term Outcomes in Patients with Gastroparesis 2021

Jejunal Perforation Secondary to Disseminated Histoplasmosis 2021

Hospital Variation in Readmissions and Visits to the Emergency Department Following Ileostomy Surgery.  24:2602-2612. 2020

Looking Ahead: the SSAT Strategic Plan Version 2.0 for the Next Decade.  24:2441-2446. 2020

Correction to: Characteristics and Outcomes of Patients Undergoing Debridement of Pancreatic Necrosis (Journal of Gastrointestinal Surgery, (2010), 14, 2, (245-251), 10.1007/s11605-009-1100-7).  24:233. 2020

Timed Stair-Climbing as a Surrogate Marker for Sarcopenia Measurements in Predicting Surgical Outcomes.  23:2459-2465. 2019

Gastric Plexiform Fibromyxoma.  23:1936-1939. 2019

Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma.  23:879-881. 2019

Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease.  23:634-642. 2019

SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer.  23:433-442. 2019

Gastric Ischemic Conditioning Prior to Esophagectomy Is Associated with Decreased Stricture Rate and Overall Anastomotic Complications.  22:1501-1507. 2018

Racial Disparities After Stoma Construction Exist in Time to Closure After 1 Year but Not in Overall Stoma Reversal Rates.  22:250-258. 2018

Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies.  22:68-76. 2018

Lessons Learned from Mentors and Heroes on Leadership and Surgical Resilience.  21. 2017

Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios.  20:2052-2062. 2016

National Trends in Short-term Outcomes Following Non-emergent Surgery for Diverticular Disease.  20:1376-1387. 2016

Racial Disparities in Readmissions for Patients with Inflammatory Bowel Disease (IBD) After Colorectal Surgery.  20:985-993. 2016

The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy.  20:262-276. 2016

Trends in Receipt and Timing of Multimodality Therapy in Early-Stage Pancreatic Cancer.  20:93-103. 2016

Postoperative Ileus—More than Just Prolonged Length of Stay?.  19:1684-1690. 2015

Characterizing Readmission in Ulcerative Colitis Patients Undergoing Restorative Proctocolectomy.  19:564-569. 2015

Quantifying the Burden of Complications Following Total Pancreatectomy Using the Postoperative Morbidity Index: A Multi-Institutional Perspective.  19:506-515. 2015

Surgical Site Infections (SSIs) After Stoma Reversal (SR): Risk Factors, Implications, and Protective Strategies.  19:327-334. 2015

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?.  19:80-87. 2015

Routine Drainage of the Operative Bed Following Elective Distal Pancreatectomy Does Not Reduce the Occurrence of Complications.  19:72-79. 2015

Low Drain Fluid Amylase Predicts Absence of Pancreatic Fistula Following Pancreatectomy.  18:1902-1910. 2014

Cost-Effectiveness of Elective Laparoscopic Cholecystectomy Versus Observation in Older Patients Presenting with Mild Biliary Disease.  18:1616-1622. 2014

Internal Hernia After Laparoscopic Roux-en-Y Gastric Bypass.  18:250-256. 2014

Trends in Treatment and Survival in Older Patients Presenting with Stage IV Colorectal Cancer.  18:369-377. 2014

A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy.  18:172-180. 2014

The Concept of Laparoscopy-Assisted Pancreatobiliary EUS (LAP-EUS).  17:1020-1023. 2013

Combined Portal Vein Resection for Hilar Cholangiocarcinoma: A Meta-analysis of Comparative Studies.  17:1107-1115. 2013

Early Versus Late Adhesiolysis for Adhesive-Related Intestinal Obstruction: A Nationwide Analysis of Inpatient Outcomes.  17:288-297. 2013

Effect of Surgical Approach on 30-Day Mortality and Morbidity After Elective Colectomy: A NSQIP Study.  16:1212-1217. 2012

Accumulation of Pro-Cancer Cytokines in the Plasma Fraction of Stored Packed Red Cells.  16:460-468. 2012

A Sprayable Hyaluronate/Carboxymethylcellulose Adhesion Barrier Exhibits Regional Adhesion Reduction Efficacy and Does Not Impair Intestinal Healing.  16:325-333. 2012

A Root-Cause Analysis of Mortality Following Major Pancreatectomy.  16:89-103. 2012

Endoscopic Transmural Drainage of Peripancreatic Fluid Collections: Outcomes and Predictors of Treatment Success in 211 Consecutive Patients.  15:2080-2088. 2011

Preoperative Infliximab is not Associated with an Increased Risk of Short-Term Postoperative Complications After Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis.  15:397-403. 2011

TRAIL and triptolide: An effective combination that induces apoptosis in pancreatic cancer cells.  14:252-260. 2010

The diagnosis of diverticulitis in outpatients: on what evidence?.  14:303-308. 2010

Characteristics and outcomes of patients undergoing debridement of pancreatic necrosis.  14:245-251. 2010

Routine evaluation of the distal colon remnant before Hartmann's reversal is not necessary in asymptomatic patients.  13:2260-2267. 2009

Anti-ERBB2 sh-RNA suppress both cell growth and tumor growth in ERBB2-overexpressing upper gastrointestinal adenocarcinomas.  13:1754-1761. 2009

A critical analysis of the surgical management of early-stage gallbladder cancer in the united states.  13:722-727. 2009

What to do when the pathology from last week's laparoscopic cholecystectomy is malignant and T1 or T2.  13:2037-2039. 2009

Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer.  12:1683-1690. 2008

Percutaneous transhepatic duodenal diversion for the management of duodenal fistulae.  12:1103-1109. 2008

ZM336372, A Raf-1 Activator, Causes Suppression of Proliferation in a Human Hepatocellular Carcinoma Cell Line.  12:852-857. 2008

Duodenocaval Fistula after Irradiation and Resection of a Retroperitoneal Sarcoma.  12:776-778. 2008

Strength of the evidence: Adjuvant therapy for resected pancreatic cancer.  12:657-661. 2008

Umbilical herniorrhapy in cirrhosis: Improved outcomes with elective repair.  12:675-681. 2008

The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation.  12:138-144. 2008

Computed tomography in the diagnosis of acute appendicitis: Definitive or detrimental?.  11:1417-1422. 2007

Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.  11:1515-1520. 2007

A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer.  11:813-819. 2007

An innovative option for venous reconstruction after pancreaticoduodenectomy: The left renal vein.  11:425-431. 2007

Durability of Portal Venous Reconstruction Following Resection During Pancreaticoduodenectomy.  10:1371-1375. 2006

Treatment With Gemcitabine and TRA-8 Anti-Death Receptor-5 mAb Reduces Pancreatic Adenocarcinoma Cell Viability In Vitro and Growth In Vivo.  10:1291-1300. 2006

Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors..  10:315-319. 2006

Outcomes of cholecystectomy after endoscopic sphincterotomy for choledocholithiasis.  10:292-296. 2006

Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors.  10:315-319. 2006

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality.  9:1207-1215. 2005

Idiopathic pulmonary fibrosis: How often is it really idiopathic?.  9:1053-1058. 2005

Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up?.  9:1059-1067. 2005

Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.  9:922-927. 2005

Case report: Serial percutaneous cholangioscopy with laser ablation for the management of locally recurrent biliary intraductal papillary mucinous tumor.  9:215-218. 2005

Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.  8:960-970. 2004

Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma.  8:812-823. 2004

Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.  7:364-371. 2003

Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy.  6:546-553. 2002

Concomitant Sclerosing Mesenteritis and Bile Duct Fibrosis Simulating Klatskin's Tumor.  5:658-660. 2001

Endoscopie Transanal Resection Provides Palliation Equivalent to Transabdominal Resection in Patients with Metastatic Rectal Cancer.  5:282-286. 2001

Multimodality Treatment for Patients with Hepatocellular Carcinoma: Analysis of Prognostic Factors in a Single Western Institution Series.  5:638-645. 2001

Hepatic Resection Using Intermittent Vascular Inflow Occlusion and Low Central Venous Pressure Anesthesia Improves Morbidity and Mortality.  4:162-167. 2000

Fas Expression Prevents Cholangiocarcinoma Tumor Growth.  3:374-382. 1999

Combined Cytosine Deaminase Expression, 5-Fluorocytosine Exposure, and Radiotherapy Increases Cytotoxicity to Cholangiocarcinoma Cells.  2:283-291. 1998

Complete Hepatic Resection of Metastases from Leiomyosarcoma Prolongs Survival.  2:151-155. 1998

Is Intra-Abdominal Drainage Necessary after Pancreaticoduodenectomy?.  2:373-378. 1998

Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report: Does It Safely Reduce the Blood Transfusion Requirement?.  1:461-466. 1997

Receptor-Dependent Growth Inhibition of Human Pancreatic Cancer by 9-cis Retinoic Acid.  1:174-181. 1997